Stock Snapshot from
Novavax IncAdd to My Watchlist
NVAX:USNASDAQ GSIndustry: Medical-Biomedical/Gene
- 2.04Last
- 0.01 -0.49%Today's Change
- 2.05Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.240 |
| EPS: Year Est. 12/13 ttm | -0.253 |
| EPS: Quarterly Actual 3/13 | -0.07 |
| EPS: Quarterly Est. 6/13 | -0.06 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -29.41 |
Company Description
| Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology. | |
| Revenue | $22 million |
| Net Income | $-29 million |
| Total Assets | $102 million |
| Employees | 137 |
| Web Site | www.novavax.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.